Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 14Terminated 6Recruiting 4Unknown 3Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 19Lymphoid 8Other hematologic neoplasm 7Breast 2Thoracic 1Gastrointestinal 1CNS 1

Conditions

Triple Negative Breast Neoplasms 1Multiple Myeloma 1Breast Cancer Patients Treated With T-DXd 1

Interventions

Trastuzumab 26Carboplatin 20pertuzumab 19Paclitaxel 19Cyclophosphamide 18pyrotinib 17Docetaxel 16Capecitabine 16Letrozole 14trastuzumab deruxtecan 13Radiotherapy 13Drug Therapy 13Standard of Care 11Fulvestrant 11dalpiciclib 10Specimen Handling 10Anastrozole 10pembrolizumab 9exemestane 9Epirubicin 9sacituzumab govitecan 8palbociclib 8eribulin 8abemaciclib 7Magnetic Resonance Spectroscopy 7Doxorubicin 7130-nm albumin-bound paclitaxel 7toripalimab 6Tamoxifen 6Neoadjuvant Therapy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Dexamethasone × Breast × Clear all
NCT07341867 2026-01-14

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

Dana-Farber Cancer Institute

Phase 1 Not yet recruiting
90 enrolled
BreastPlasma cell

Multiple Myeloma, Triple Negative Breast Neoplasms

NCT07254416 2025-11-28

A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients

Tianjin Medical University Cancer Institute and Hospital

Phase 4 Not yet recruiting
120 enrolled
Breast

Breast Cancer Patients Treated With T-DXd

Data powered by HemOnc (CC BY 4.0) Colophon âš¡